Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-035437
Filing Date
2020-06-10
Accepted
2020-06-10 07:37:16
Documents
1
Period of Report
2020-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5990
  Complete submission text file 0001209191-20-035437.txt   7454
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Issuer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105
Business Address
Thornton Michael Milos (Reporting) CIK: 0001706297 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37969 | Film No.: 20953497